Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experimental arrhythmia and its prevention].

L L Stazhadze, T A Ventslavskaia, V V Korzhova

    Kosmicheskaia Biologiia I Aviakosmicheskaia Meditsina
    |November 1, 1985
    PubMed
    Summary

    A new selenium compound, selenofen-24, demonstrated superior preventive antiarrhythmic effects compared to standard drugs like novocainamide. This novel agent shows promise for treating various experimental arrhythmia models.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Huntington's disease: cellular and molecular basis of pathology].

    Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova·2015
    Same author

    Optogenetic approach to the studies of synaptic transmission.

    Bulletin of experimental biology and medicine·2014
    Same author

    [Atrial fibrillation registered for the first time: characteristics of clinical course, treatment, prognosis].

    Kardiologiia·2013
    Same author

    [Clinico-economical aspects of cardioversion of paroxysmal atrial fibrillation at phehospital stage and during hospitalization].

    Kardiologiia·2012
    Same author

    [Analysis of causes of pulmonary artery embolism hypodiagnostics at prehospital stage].

    Kardiologiia·2012
    Same author

    [Prevalence of atrial fibrillation among patients under observation by an outpatient clinic].

    Kardiologiia·2012

    Area of Science:

    • Pharmacology
    • Cardiovascular Research
    • Medicinal Chemistry

    Background:

    • Arrhythmias pose a significant clinical challenge, necessitating effective preventive treatments.
    • Existing antiarrhythmic drugs have limitations in efficacy and spectrum of action.
    • Selenium-containing compounds are being explored for their therapeutic potential.

    Purpose of the Study:

    • To evaluate the preventive antiarrhythmic efficacy of a novel selenium derivative, selenofen-24.
    • To compare selenofen-24's antiarrhythmic profile with established drugs: novocainamide, isoptin, and inderal.
    • To assess selenofen-24's effectiveness across diverse experimental arrhythmia models.

    Main Methods:

    • Experimental induction of arrhythmias using agents like aconitine, strophanthin, pituitrin, and calcium chloride.
    • Administration of selenofen-24 and comparator drugs to establish preventive effects.
    • Comparative analysis of the spectrum of action and efficacy of the tested compounds.

    Main Results:

    • Selenofen-24 exhibited a notable preventive antiarrhythmic effect in multiple experimental models.
    • The compound demonstrated an advantageous spectrum of action compared to novocainamide, isoptin, and inderal.
    • Efficacy was observed across various pro-arrhythmic challenges, including chemical and electrical stimuli.

    Conclusions:

    • Selenofen-24 presents a promising novel agent for the prevention of experimental arrhythmias.
    • Its broader spectrum of action suggests potential advantages over currently used antiarrhythmic therapies.
    • Further investigation into selenofen-24's mechanism and clinical utility is warranted.

    Related Experiment Videos